Skip to main content
Clinical Trials/CTRI/2023/05/052349
CTRI/2023/05/052349
Active, not recruiting
Phase 2

A Clinical study to evaluate the efficacy of Khasa beeja tailam (Seed oil of Papaver somniferum) in Darunaka Vyadhi. - A Clinical study to evaluate the efficacy of khasa beeja tailam (Seed oil of Papaver somniferum) in Darunaka Vyadhi

Central council for Research in Ayurveda Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central council for Research in Ayurveda Sciences
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central council for Research in Ayurveda Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects in General good health of either sex. (Subjects without other specific health
  • complaints.)
  • 2\. Subjects within the age group of 18\-55 years.
  • 3\. Subjects willing to give a written informed consent and willing to abide by and
  • comply with the study protocol.
  • 4\. Subject exhibiting a slight to moderate dandruff or Seborrheic dermatitis of scalp on
  • the total adherent and non adherent score after clinical examination, on Day 0\.
  • 5\. Subject having stopped any possible antidandruff treatment at least 2 weeks prior to

Exclusion Criteria

  • 1\. Associated with other dermatological conditions such as psoriasis etc.
  • Other Systemic illness.
  • 2\. Pregnant, lactating mothers, menopausal women.
  • 3\. Any Immuno\-compromised patients and uncontrolled Diabetes
  • 4\. Systemic treatment with corticosteroids, antibiotics, immune\-suppressants etc, or any
  • modern treatment within 3 months before of this trial.
  • 5\. Subjects who have undergone hair growth treatment within 3 months before screening
  • into the study. Subjects, who have history of alcoholism, smoking, crash dieting and/or
  • psychiatric disorder including trichotillomania. Subjects who have had hair
  • transplantation, who have taken pharmaceutical product which cause hirsutism(ex.phenytoin) and finasteride for androgenic alopecia, under medical treatment for

Outcomes

Primary Outcomes

Not specified

Similar Trials